Skip to main content
NIH funding notice RFA-AG-18-019

Enhancing Central Neural Control of Mobility in Aging (U01 Clinical Trial Optional)

Closed on February 21, 2018.

Posted
October 25, 2017
Close date
February 21, 2018
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,269,720 in first-year total cost, median $1,134,860.

Most frequent study sections

  1. Special Emphasis Panel[ZAG1 ZIJ-3 (A1)]2

Most frequent institutions

  1. UNIVERSITY OF FLORIDA1
  2. UNIVERSITY OF PITTSBURGH AT PITTSBURGH1
Competing awards under RFA-AG-18-019 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2018Neurobiological drivers of mobility resilience: the dopaminergic system1U01AG061393-01BOHNEN, NICOLAAS IDAROSANO, CATERINAUNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA$1,288,819ZAG1
2018Multimodal imaging of brain activity to investigate walking and mobility decline in older adults1U01AG061389-01CLARK, DAVID JMANINI, TODDSEIDLER, RACHAEL DUNIVERSITY OF FLORIDA, FL$980,901ZAG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-11-0.1.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-AG-18-019: Enhancing Central Neural Control of Mobility in Aging (U01 Clinical Trial Optional) | ScienceDex | ConductScience